Clinical Trial Update: Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

View source ↗

Summary

A Yale University trial is evaluating immune responses to COVID-19 vaccination in immunodeficient patients, including those with Multiple Sclerosis, autoimmune …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Blistering Diseases
• B-cell Deficiency
• Multiple Sclerosis

Snippet

Sponsor: Yale University | Conditions: Multiple Sclerosis, Autoimmune Blistering Disease | Status: ACTIVE_NOT_RECRUITING